Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
Clinical trial NCT04002674 · COMPLETED
Trial details
- NCT number
- NCT04002674
- Sponsor
- Georgetown University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2025-04-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.